EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness

Katherine Jennings, Cuixia Tian iD, Rebeccah L Brown iD, Paul S Horn iD, Benedikt Schoser iD, Hani Kushlaf iD, Nikolai A Timchenko, Lubov Timchenko

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Katherine Jennings und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Cincinnati Children's Hospital, 3333 Burnet Ave., Cincinnati, OH 45229, USA. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Glycogen Synthase Kinase 3 beta, Muscle Weakness. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myotonic Dystrophy type 1 (DM1) is a complex disease affecting multiple tissues, including skeletal and cardiac muscles, the brain and the eyes. DM1 results from an expansion of CTG repeats in the 3′ UTR of the DMPK gene. Previously, we described that the small-molecule inhibitor of GSK3β, tideglusib (TG), reduces DM1 pathology in DM1 cell and mouse models by correcting the GSK3β-CUGBP1 pathway, decreasing the mutant CUG-containing RNA. Respectively, clinical trials using TG showed promising results for patients with congenital DM1 (CDM1). The drug development in DM1 human studies needs specific and noninvasive biomarkers. We examined the blood levels of active GSK3β in different clinical forms of DM1 and found an increase in active GSK3β in the peripheral blood mononuclear cells (PBMCs) in patients with CDM1, juvenile DM1 and adult-onset DM1 vs. unaffected patients. The blood levels of active GSK3β correlate with the length of CTG repeats and severity of muscle weakness. Thrombospondin and TGFβ, linked to the TG-GSK3β pathway in DM1, are also elevated in the DM1 patients’ blood. These findings show that the blood levels of active GSK3β might be developed as a potential noninvasive biomarker of muscle weakness in DM1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyGlycogen Synthase Kinase 3 betaMuscle WeaknessHumansFemaleMaleAdultMiddle AgedBiomarkersChildTrinucleotide Repeat ExpansionLeukocytes, MononuclearAdolescentMyotonin-Protein KinaseYoung AdultThiadiazoles

Stichwörter der Autor:innen

CTG repeatsGSK3β kinaseMyotonic Dystrophy type 1

Substanzen

Glycogen Synthase Kinase 3 betaBiomarkersMyotonin-Protein KinasetideglusibGSK3B protein, humanThiadiazoles

Autor:innen und Institutionen

  • Division of Neurology, Cincinnati Children's Hospital, 3333 Burnet Ave., Cincinnati, OH 45229, USA.
  • Department of Pediatrics, University of Cincinnati, 2600 Clifton Ave., Cincinnati, OH 45221, USA.
  • Department of Surgery, Cincinnati Children's Hospital, 3333 Burnet Ave., Cincinnati, OH 45229, USA.
  • Department of Neurology, Friedrich-Baur-Institute, LMU Clinics, Ludwig-Maximilians-University, Ziemssenstr., 80336 Munich, Germany.
  • Department of Neurology & Rehabilitation Medicine, University of Cincinnati, 260 Stetson St., Cincinnati, OH 45219, USA.

ORCID-Profile: Cuixia Tian, Rebeccah L Brown, Paul S Horn, Benedikt Schoser, Hani Kushlaf

Förderung

  • NIAMS NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • Cincinnati Children’s Hospital Research Development Funds

Zitieren

APA

Jennings, K., Tian, C., Brown, R. L., Horn, P. S., Schoser, B., Kushlaf, H., Timchenko, N. A., & Timchenko, L. (2025). Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110760

Vancouver

Jennings K, Tian C, Brown RL, Horn PS, Schoser B, Kushlaf H, et al. Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110760

BibTeX
@article{Jennings2025,
  author = {Jennings, Katherine and Tian, Cuixia and Brown, Rebeccah L and Horn, Paul S and Schoser, Benedikt and Kushlaf, Hani and Timchenko, Nikolai A and Timchenko, Lubov},
  title = {Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110760}
}
Kostenlos starten →